Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Cloning the sterol carrier protein 2 genes of Japanese toad (Bufo japonicus formosus) and Chinese toad (Bufo gargarizans) and its tissue expression analysis.
???displayArticle.abstract???
In this study, to clarify the bioactive polypeptides included in the skins and secretions of Bufo, we screened the Japanese toad (Bufo japonicus formosus) skin cDNA liary by colony polymerase chain reaction (PCR), and obtained a transcript of 1 075 bp consisting of 1 37 bp 5' untranslated region (UTR), 515 bp 3' UTR and a 423 bp open reading frame (ORF) encoding a polypeptide of 140 amino acid residues (GenBank accession number: KF359945). Homolog analysis showed a 70%-96% homology with sterol carrier protein-2 (SCP-2) present in other animals, which is implicated in lipid metabolism of other organisms. The gene SCP-2 of Chinese toad (B. gargarizans) was cloned from a first strand cDNA of Bufo skin (GenBank accession number: KF381341) via PCR, whose encoding polypeptide has only one amino acid difference from that of Japanese toad. Tissue distribution analysis showed that SCP-2 expressed in all organs tested, though in the liver and spleen it manifested lower expression than in other organs. These findings might indicate SCP-2 being one of the active ingredients in toad skin. These findings may in turn have implications for further drug development from traditional Chinese medicine sources.
Castelli,
Epidemiology of coronary heart disease: the Framingham study.
1984, Pubmed
Castelli,
Epidemiology of coronary heart disease: the Framingham study.
1984,
Pubmed Clarke,
The natural history of amphibian skin secretions, their normal functioning and potential medical applications.
1997,
Pubmed Cui,
Overexpression of Sterol Carrier Protein 2 in patients with hereditary cholesterol gallstones.
2011,
Pubmed Efferth,
Activity of drugs from traditional Chinese medicine toward sensitive and MDR1- or MRP1-overexpressing multidrug-resistant human CCRF-CEM leukemia cells.
2002,
Pubmed Hu,
[Bufo gargarizans mcl-1 cloning and its prokaryotic recombinant protein expression].
2013,
Pubmed Kriska,
Sterol carrier protein-2 (SCP-2) involvement in cholesterol hydroperoxide cytotoxicity as revealed by SCP-2 inhibitor effects.
2010,
Pubmed McLean,
Altered ovarian sterol carrier protein expression in the pregnant streptozotocin-treated diabetic rat.
1996,
Pubmed Novković,
DADP: the database of anuran defense peptides.
2012,
Pubmed Osumi,
Purification and properties of acyl-CoA oxidase from rat liver.
1980,
Pubmed Qi,
Antitumor activity of extracts and compounds from the skin of the toad Bufo bufo gargarizans Cantor.
2011,
Pubmed Qi,
[Apoptosis-inducing effect of cinobufacini on human hepatoma cell line HepG2 and its mechanism of action].
2010,
Pubmed Rash,
De novo sequencing of peptides from the parotid secretion of the cane toad, Bufo marinus (Rhinella marina).
2011,
Pubmed Schroeder,
Pro-sterol carrier protein-2: role of the N-terminal presequence in structure, function, and peroxisomal targeting.
2000,
Pubmed Schroeder,
Sterol carrier protein-2: new roles in regulating lipid rafts and signaling.
2007,
Pubmed Wu,
[In vitro anti-proliferation effect of peptides from cinobufacini injection].
2012,
Pubmed Zhao,
Comprehensive transcriptome profiling and functional analysis of the frog (Bombina maxima) immune system.
2014,
Pubmed Zhuge,
[Cloning and bioinformatic analysis of TAGLN2 cDNA of Bufo japonicus formosus].
2013,
Pubmed
,
Xenbase
